SUBSCRIBE
IQVIA Blog Digest
For all the latest industry insights, please subscribe to the IQVIA U.S. blog digest.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
WHO WE HELP
-
Pharmaceutical Manufacturers
-
Emerging Biopharma
-
MedTech
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsMedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialty and Patient Advocacy
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSBlog
Interoperability: What is FHIR? - Part 2 in a series
Jun 10, 2021
In part one of our two-part series, we provided a high-level overview of the origins and implication of the Fast Healthcare Interoperability Resources standard, or FHIR. While to date, there is no known timeframe determined for implementation of the standards by payers and providers in the Cures Act, what is known is that a day is coming.
Recall that The Cures Act defines in the Trusted Exchange Framework and Common Agreement (TEFCA) that healthcare providers and their businesses will be required to use Application Programming Interfaces (APIs) to exchange information, but no guidance has yet been provided as to when they must be used. Similarly, payer organizations are encouraged to follow the standards, but no mandates have been issued for payer organizations to adhere to the standards, as well.
Despite the lack of deadline, it is important that your business begins its preparations for implementation today.
While Health Level 7 International (HL7) has defined the data exchange standards in FHIR, organizations will need to determine how the data fields in their specific systems will get mapped back to the data fields defined in the standards. While FHIR standards define what information needs to be included in a specific exchange transaction, it’s up to each organization to determine how to get their source system data identified, accessible, and mapped (via APIs) to external healthcare entities and patients.
This means that while businesses may be exchanging information as required by the HL7 standards, the methods of data collection and the means of making internal data available via APIs will vary widely between organizations. Many of the Cures Act standards require specific healthcare data to be used, such as the United States Core Data for Interoperability (USCDI) when a healthcare data exchange is being completed.
These standards may demand the addition of new data elements, such as the Systemized Nomenclature of Medicine (SNOMED) code sets, to be compliant.
It’s likely that your organization has not exchanged health information in this way, or with these standards. A considerable number of large health systems are just getting started in this type of data sharing. If this is the case for your organization, not only do you have to pick a technology platform (or write the software yourself), you also must determine where this data will be sourced from and where it should be stored within your technology ecosystem.
Performing the analysis on your data and how it maps to the new standards can be a daunting task. Fortunately, professional services exist that can perform the necessary analysis, identify your source datasets, reveal how to map that data into the defined standards, and help define a solution that will make those data elements available for FHIR-based API services.
While we strive to find our way to the other side of the COVID-19 pandemic, preparing for the Cures Act is vital work for healthcare organizations in their effort to provide the best care possible. Once more, you can look to IQVIA for assistance with these services. The accurate and efficient exchange of healthcare information benefits us all.
Catch up on the Cures Act
Are you ready for July 1, 2021?